FDA-cleared K191278
RSI-MRI+
MultiModal Imaging Services Corporation (dba HealthLytix)
RSI-MRI+ is indicated for use as automatic post-acquisition image processing software for analysis of diffusion-weighted and anatomical magnetic resonance imaging data. RSI-MRI+...
- Modality
- MRI
- Anatomy
- Prostate
- Decision
- 2019-11-19